Assuming benefit is required, the following results were found.

  • Pharmacy Benefit Managers and Their Role in Drug Spending - Are they the Good Guys or Bad Guys

    April 2019 Pharmacy benefit manager have a significant behind-the-scenes impact in determining drug costs and patients’ access to medications. Some experts think pharmacy benefit managers need to move their business model away from securing rebates...

    https://mschristian.org/index.php/blog/pharmacy-benefit-managers-and-their-role-in-drug-spending-are-they-the-good-guys-or-bad-guys
  • #ECTRIMS2019 - Mayzent's Benefits for MS Patients a 'Key Question,' Says EXPAND's Principal Investigator - Multiple Sclerosis News Today

    The most recent data continue to support Mayzent‘s (siponimod) benefits and provide more insights on how this therapy can make a difference for those with relapsing forms of multiple sclerosis (MS) — in particular, data showing the therapy lowers the...

    https://mschristian.org/index.php/blog/ectrims2019-mayzent-s-benefits-for-ms-patients-a-key-question-says-expand-s-principal-investigator-multiple-sclerosis-news-today
  • Robotic exoskeleton helps woman with multiple sclerosis walk - WJXT News4JAX

    MS patients at Cleveland Clinic taking part in a research study to see if a special robotic brace, or exoskeleton, will benefit her mobility. “By doing what we would call a ‘forced use,’ the hope is that you’ll reprogram the brain so that it actually...

    https://mschristian.org/index.php/blog/robotic-exoskeleton-helps-woman-with-multiple-sclerosis-walk-wjxt-news4jax
  • Cardiac Rehab Might Benefit Stroke Survivors, Too

    (MedPage Today) -- Mixed aerobics and walking was most beneficial Original link (MedPage Today) -- Mixed aerobics and walking was most beneficial Original link

    https://mschristian.org/index.php/blog/cardiac-rehab-might-benefit-stroke-survivors-too
  • Events Calendar | Carson City Nevada News - Carson Now

    Senior that will be delivered to local retirement homes. On Feb. 15 Carson Mall will host Family Bingo Night. Proceeds will benefit Carson High School’s Safe and Sober Grad Night. Original link Carson Mall, 1223 South Carson Street, in Carson City will...

    https://mschristian.org/index.php/blog/events-calendar-carson-city-nevada-news-carson-now
  • A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS

    challenges and proposing a new approach for measuring the prevalence of MS in the United States, we hope that our work will benefit scientists who study neurologic and other chronic conditions for which nationalprevalence estimates do not exist. Much...

    https://mschristian.org/index.php/blog/a-new-way-to-estimate-neurologic-disease-prevalence-in-the-united-states-illustrated-with-ms
  • Nuvaira Announces Chief Financial Officer and Pivotal Study Milestone - P&T Community

    opportunity for me to be part of a dynamic and pioneering company that is deploying truly disruptive technologies that will benefit patients and provide value to physicians and the healthcare system," said Mr. Griffin. "The company has an exciting...

    https://mschristian.org/index.php/blog/nuvaira-announces-chief-financial-officer-and-pivotal-study-milestone-p-t-community
  • Got MS Brain Fog? These 4 Foods Can Help

    and has been shown to help fight fatigue. More specifically, one study found that those with chronic fatigue syndrome could benefit from adding more omega-3s to their diet. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), both of which are...

    https://mschristian.org/index.php/blog/got-ms-brain-fog-these-4-foods-can-help
  • Endonovo Therapeutics Provides SofPulse® To All NFL Teams [Updated] - GlobeNewswire

    and reduces inflammation by improving blood flow. We believe that injured NFL players undergoing medical procedures will benefit greatly from the SofPulse® technology.” About Endonovo Therapeutics Email Print Friendly Share December 23, 2019 09:48...

    https://mschristian.org/index.php/blog/endonovo-therapeutics-provides-sofpulse-to-all-nfl-teams-updated-globenewswire
  • 10 Worst-Performing Stocks of 2019 - Motley Fool

    has decided not tospin off the company for now, saying when reporting third-quarter earnings that ANGI Homeservices would benefit from staying part of the internet conglomerate. ANGI Homeservices is spending aggressively to pursue growth and seems to...

    https://mschristian.org/index.php/blog/10-worst-performing-stocks-of-2019-motley-fool
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management. By: Aaron Boster, MD Published: December 02, 2019 As the field of neuroimmunology evolves at an unprecedented rate, keeping up with the latest...

    https://mschristian.org/index.php/blog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • Athletico Physical Therapy Opens in Sylvania - P&T Community

    progress through rehabilitation to perform at their highest level.Dry needling – If you are experiencing pain, you may benefit from dry needling. This technique involves placing ultra-thin needles into painful areas of the body to stimulate the...

    https://mschristian.org/index.php/blog/athletico-physical-therapy-opens-in-sylvania-p-t-community
  • With Bristol-Myers CVR, Investors Can Bet on 3 Drugs in Celgene’s Pipeline - Barron's

    to compensate them if major drugs in the Celgene pipeline get approved and Bristol-Myers derives significant financial benefit. The CVR was changing hands on Wednesday morning under the ticker BQBBV at $2.23, up 35.5 cents on the session. It is expected...

    https://mschristian.org/index.php/blog/with-bristol-myers-cvr-investors-can-bet-on-3-drugs-in-celgene-s-pipeline-barron-s
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    and Research in Multiple Sclerosis (ECTRIMS) Conference, recently held in Stockholm, in which two speakers discussed the benefits and risks of low- versus high-efficacy disease-modifying treatments (DMTs). Gisela Kobelt, PhD, a health economist and...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Humira, Rituxan top list of U.S. drugs with biggest price increases: report - Physician's Weekly

    but they also negotiate discounts and after-market rebates with purchasers and their representatives such as pharmacy benefit managers, health insurers, employers, andgovernment and state health coverage programs. ICER evaluated the pricing in...

    https://mschristian.org/index.php/blog/humira-rituxan-top-list-of-u-s-drugs-with-biggest-price-increases-report-physician-s-weekly
  • The MS Coalition invites you to join us for the 2019 Multiple Sclerosis Summit on Saturday, November 9, 2019 at the Westin Lombard, Illinois

    sponsored by the member organizations of the MS Coalition, a cooperative effort of nine national organizations working to benefit people with MS. Members include: Accelerated Cure Project, the Consortium of MS Centers, Can Do Multiple Sclerosis, the...

    https://mschristian.org/index.php/blog/the-ms-coalition-invites-you-to-join-us-for-the-2019-multiple-sclerosis-summit-on-saturday-november-9-2019-at-the-westin-lombard-illinois
  • Siponimod Delays Time to Wheelchair in Secondary Progressive MS - Neurology Times

    analysis of the EXPAND study population has suggested that siponimod (Mayzent, Novartis) may have an additional long-term benefit for patients with secondary progressive multiple sclerosis (MS) beyond the study’s core findings. The oral selective...

    https://mschristian.org/index.php/blog/siponimod-delays-time-to-wheelchair-in-secondary-progressive-ms-neurology-times
  • Brain's lymphatic vessels as new avenue to treat multiple sclerosis

    that." But the lab's recent research also highlights the complexity doctors face when trying to manipulate the vessels to benefit human health. For example, blocking the vessels had a benefit in the multiple sclerosis model, but the lab has also shown...

    https://mschristian.org/index.php/blog/brain-s-lymphatic-vessels-as-new-avenue-to-treat-multiple-sclerosis
  • What to know about optic neuritis and MS

    damage is called optic neuritis. Although the symptoms of optic neuritis tend to subside over time, some people may also benefit from various treatments. Visual disturbances are among the most common symptom that people with MS have. One study found...

    https://mschristian.org/index.php/blog/what-to-know-about-optic-neuritis-and-ms
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    rebound,” she added. Of note, more data on Tysabri was presented at ECTRIMS 2019. That data support Tysabri’s long-term benefit for people with early relapsing-remitting MS (RRMS). It also showed that Tysabri can reduce disease relapse rates when given...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds

Results 1 - 20 of 30
 
 

Follow Us on Twitter

Follow Us On Twitter - Image